iShares S&P Global Healthcare
ALTAR
Score™
6.6% info Recommen-
dation
OVERWEIGHT
2019E    2020E
P/E
ratio
17.4x P/Sales
ratio
1.9x
P/BV
ratio
3.5x Div.
yield
2.0%


  • Description
  • Performance
  • Comps
  • premium Fundamentals
  • premium Valuation
  • premium Rating
iShares S&P Global Healthcare Sector Index Fund seeks investment results that correspond to the performance of the S&P Global Healthcare Index. The Fund uses a Representative Sampling strategy

FUND BASICS
Category Global Equities
Fund Sponsor Barclays Global Fund Advisors
Website www.ishares.com
Inception date Nov 21, 2001
Assets (mns) $1,943
Currency USD
Expense ratio 46 bp
Distributions Semi-Annually

FUND STRUCTURE
Regulation Open-Ended Fund
Custodian State Street Bank & Trust
Weighting Market Cap
Index replication n/a
Uses derivatives No
Options available Yes

SECTOR BREAKDOWN

 


CONSTITUENT BREAKDOWN
No. of constituents 106
Wgt avg mkt cap (mns) $128,150
Large cap (>$10bn) 97.4%
Mid cap ($2-10bn) 2.6%
Small cap (<$2bn) 0.0%
Developed mkts 99.7%
Emerging mkts 0.3%

TOP TEN HOLDINGS
JOHNSON & JOHNSON 6.7 %
UNITEDHEALTH GROUP INC 4.6 %
NOVARTIS AG-REG 4.3 %
MERCK & CO. INC. 4.1 %
ROCHE HOLDING AG-GENUSSCHEIN 4.0 %
PFIZER INC 3.9 %
ABBOTT LABORATORIES 2.8 %
MEDTRONIC PLC 2.7 %
AMGEN INC 2.5 %
ABBVIE INC 2.4 %
Total 38.1 %

TOP COUNTRY EXPOSURE
UNITED STATES 63.6 %
SWITZERLAND 10.0 %
JAPAN 6.1 %
BRITAIN 5.0 %
IRELAND 4.0 %
GERMANY 2.4 %
DENMARK 2.3 %
AUSTRALIA 2.0 %
FRANCE 2.0 %
NETHERLANDS 0.9 %

HISTORICAL PERFORMANCE info

  Custom date range Compare to  
  thru


Standardized Annual Returns (thru October 31)
Year-to-date 1 year 5 years 10 years Since Incep.
14.1% 10.8% 7.0% 12.6% 7.2%

Market Correlations
versus... Beta R-squared
S&P500 0.76 63%
MSCI EAFE 0.73 50%
MSCI Emg. Mkts. 0.52 41%

Technical Indicators
Recent close $64.55
30d moving avg. $62.33
Annualized volatility 11.5%
Short interest (ETF) 0.3%
Relative strength (RSI) 69

Liquidity measures
Avg. volume (thou.) 101
Turnover 0.3%
Bid/Ask (% of price) 0.09%
ADV underlying (mns) $23,740

Distributions


FINDING ALTERNATIVE FUNDS

Below is a list of 20 potential alternatives to the iShares S&P Global Healthcare ETF based on the alternatives' overlap in portfolio holdings with IXJ. Consider funds with lower expense ratios and/or higher ALTAR Score™ ratings as possible alternatives.

Benchmark ticker: IXJ Expense: 46 bp ALTAR Score™: 6.6%


ALTERNATIVE ETFs BASED ON OVERLAP WITH IXJ
Ticker Fund
Name
Overlap1
vs IXJ
(%)
Expense
ratio
(bp)
Savings
vs IXJ
(bp)
ALTAR
Score™
(%)
ALTAR
vs IXJ
(%)
XLV Health Care Select Sector SPDR 67.7 13 33 7.5 +0.9
FHLC Fidelity MSCI Health Care 67.7 8 38 6.1 -0.5
VHT Vanguard Health Care 67.7 10 36 6.1 -0.5
IYH iShares US Healthcare 66.6 43 3 6.6 -0.0
JHMH John Hancock Multifactor Health Care 63.7 40 6 6.9 +0.4
RYH Invesco S&P Equal Weight Healthcare 50.0 40 6 7.3 +0.7
IEHS iShares Evolved U.S. Healthcare Staples 40.5 18 28 6.1 -0.5
GDNA Goldman Sachs Motif Human Evolution 35.5 50 -4 1.0 -5.6
IEIH iShares Evolved U.S. Innovative Healthcare 34.9 18 28 4.9 -1.7
FXH First Trust Health Care Alphadex 32.2 63 -17 7.4 +0.8
PJP Invesco Dynamic Pharmaceuticals 30.7 56 -10 9.9 +3.3
FTXH First Trust Nasdaq Pharmaceuticals 24.9 60 -14 5.6 -1.0
LNGR Global X Longevity Thematic 24.9 50 -4 3.7 -2.9
HLAL Wahed FTSE USA Shariah 22.8 50 -4 5.7 -0.9
PPH VanEck Vectors Pharmaceuticals 21.1 36 10 9.6 +3.0
IHE iShares DJ US Pharmaceuticals 20.8 42 4 5.6 -1.0
DURA VanEck Vectors Morningstar Durable Dividend 20.6 29 17 6.8 +0.2
MGV Vanguard Mega Cap 300 Value 20.6 7 39 7.1 +0.5
XT iShares Exponential Technologies 20.1 47 -1 5.4 -1.2
HTEC Robo Global Healthcare Technology and Innovation 20.0 68 -22 0.0 -6.6

1Overlap is the percentage of holdings by weight that are identical. For example, if Fund A has a 2% position in Apple, Inc. (AAPL) and Fund B has a 5% position, their overlapping position in AAPL is 2%.

Content on this tab for subscribers only**

RESULTS & ESTIMATES

  2014 2015 2016 2017 2018 2019E 2020E
Sales per share ** ** ** ** ** ** **
Earnings per share ** ** ** ** ** ** **
Dividends per share info ** ** ** ** ** ** **
Book value per share ** ** ** ** ** ** **

 

Sales per share growth   **% **% **% **% **% **%
EPS growth   **% **% **% **% **% **%

Sales per share growth   **% **% **% **% **% **%
EPS growth   **% **% **% **% **% **%

OTHER FUNDAMENTAL METRICS

Long term EPS growth est. **%   Debt-to-equity **x
Asset turnover **%   Assets-to-equity **x

Return on equity

Revision activity*
*Six months ago = 100

Net margins

Compound annual growth rates

Content on this tab for subscribers only

VALUATION METRICS
  2018 2019E 2020E
Price-to-sales ** ** **
Price-to-earnings ** ** **
Price-to-cash flow ** ** **
Price-to-growth ** ** **
Price-to-book value ** ** **
Yield ** ** **

Historical valuation trends

Forward
multiple:
iShares S&P Global Healthcare
Relative
to:
S&P500 MSCI EAFE MSCI Emg. Mkts. Other ETF:

OVERWEIGHT

Above average appreciation potential. A rating of OVERWEIGHT is assigned to ETFs with ALTAR Scores in the 4th quintile (ranking higher than 60%-80%) of their category. Typically, funds in this category consist of stocks trading at attractive valuations and/or having above-average fundamentals.

ALTAR Score™


Calculation of ALTAR Score™
Avg. Return on Equity 21.6 %
Divided by: Fwd. P/BV 3.1 x
Less: Expense ratio 46 bp
Equals: ALTAR Score 6.6 %
info More information on ALTAR Score™

MODERN PORTFOLIO THEORY info

CONSENSUS RECOMMENDATIONS: FUND CONSTITUENTS
COMPOSITE
RATING
1.45 CATEGORY
AVERAGE
1.54
 
The composite rating is a weighted average of analysts' consensus recommendations for individual ETF constituents, based on the following scale:

BUY = 1; OVERWEIGHT = 1.5, HOLD = 2; UNDERWEIGHT = 2.5; and SELL = 3.

Readers are cautioned that because analyst ratings tend to be inflated, the composite score may be more useful as a relative measure of sentiment between funds rather than as a stand-alone recommendation.
 

 

See RATING tab for calculation of ALTAR Score™
Risk & reward. Uses std. dev. as proxy for risk, ALTAR Score™ for return forecast.
Dividends paid by constituents to the fund. May differ from actual distributions to shareholders due to constituent changes, timing issues or other factors.
Monthly returns based on changes in price plus dividends. May differ from daily returns reported by funds. See below for standardized returns.